Study: GlySure's continuous glucose monitoring looks good in the ICU

September 5, 2013 by Ingrid Mezo

GlySure touts clinical results showing its continuous blood glucose monitoring technology is effective and safe and that it may alert caregivers earlier about hypoglycemic and hyperglycemic events.

Study shows Glysure’s continuous blood glucose monitoring system works in ICU

GlySure's in-hospital continuous blood glucose monitoring systems may help cut down on blood-sampling frequency while allowing giving earlier warnings of hypoglycemic and hyperglycemic events in patient in critical care, according to the results of a clinical study that GlySure presented during the World Federation of Societies of Intensive & Critical Care Medicine Congress in South Africa last week.

The GlySure system provided blood glucose concentration findings consistent with those found in traditional blood draws in a study of 24 post-surgical cardiac surgery patients in an intensive care unit, according to England-based GlySure.

Sign up to get our free newsletters delivered right to your inbox.

"We are excited by these results," principal investigator Dr. Krishna Prasad said on behalf of the company. "A device like this would be extremely valuable in managing these kinds of patients in the ICU. The system is also easy to set up and use, which are key requirements in critical care."